During the past decade, Fondazione IRCCS Policlinico San Matteo conducted 269 clinical trials. In the 10-year time frame, 269 clinical trials started and 75 clinical trials were completed, i.e. on average, 27.9% percent of trials that started reached the finish line to date. In the past 5 years, 127 clinical trials started and 59 clinical trials were completed. i.e. 46.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fondazione IRCCS Policlinico San Matteo" #1 sponsor was "IRCCS Policlinico S. Matteo" with 46 trials, followed by "Celgene" with 33 trials sponsored, "Janssen Research & Development, LLC" with 14 trials sponsored, "University of Pavia" with 13 trials sponsored and "Boehringer Ingelheim" with 13 trials sponsored. Other sponsors include 307 different institutions and companies that sponsored additional 193 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione IRCCS Policlinico San Matteo" #1 collaborator was "IRCCS Policlinico S. Matteo" with 11 trials as a collaborator, "University of Pavia" with 6 trials as a collaborator, "Istituto Di Ricerche Farmacologiche Mario Negri" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator and "National Cancer Institute (NCI)" with 4 trials as a collaborator. Other collaborators include 339 different institutions and companies that were collaborators in the rest 301 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione IRCCS Policlinico San Matteo" are "Multiple Myeloma" (17 trials), "Pulmonary Arterial Hypertension" (11 trials), "Breast Cancer" (9 trials), "Crohn Disease" (7 trials) and "Heart Failure" (7 trials). Many other conditions were trialed in "Fondazione IRCCS Policlinico San Matteo" in a lesser frequency.

Most popular intervention types in "Fondazione IRCCS Policlinico San Matteo" are "Drug" (282 trials), "Other" (60 trials), "Device" (38 trials), "Procedure" (32 trials) and "Biological" (22 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (71 trials), "Dexamethasone" (12 trials), "Rituximab" (10 trials), "Cyclophosphamide" (9 trials) and "Durvalumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione IRCCS Policlinico San Matteo" are 401 trials for "All" genders, 23 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 150 active trials in "Fondazione IRCCS Policlinico San Matteo". 1 are not yet recruiting, 87 are recruiting, 57 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 186 completed trials in Fondazione IRCCS Policlinico San Matteo, 4 suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione IRCCS Policlinico San Matteo, 20 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 167 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 29 trials, and there were also 41 trials that are defined as “Not Applicable".

Fondazione IRCCS Policlinico San Matteo has several departments that took part in Clinical trials: "S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo" - 46 trials, "Fondazione IRCCS Policlinico San Matteo, Oncologia" - 5 trials, "Med. Int. ed Oncologia Medica IRCCS Policlinico S. Matteo" - 5 trials, "Urology Department Fondazione IRCCS Policlinico San Matteo" - 4 trials, "Irccs Policlinico San Matteo; Reumatologia Adulti" - 3 trials, "Fondazione Irccs Policlinico San Matteo - Cardiologia" - 3 trials, "Fondazione Irccs Policlinico "San Matteo" - Struttura Complessa Di Neonatologia, Patologia Neonatale E Terapia Intensiva" - 2 trials, "Department of Pediatrics University of Pavia, Policlinico San Matteo" - 2 trials